Samsung Bioepis Marks a New Chapter in the Biosimilar Industry with Groundbreaking Advancements, Exclusive Interview by Xtalks

no thumb

In an interview by Xtalks, company leaders at Samsung Bioepis, Ilsun Hong and Thomas Newcomer, discuss the company’s advancements in the biosimilar industry. They discuss the FDA approval for both high- and low-concentration formulations of their adalimumab biosimilar and the…

Source link

The author

Leave a Response